TereLabs SRL
TereLabs reported total assets of 207,737 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026).
The score of TereLabs shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
TereLabs's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
TereLabs's financial analysis
- Solvency78.1%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of TereLabs
TereLabs's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1004.932.767
- VAT number
- BE1004932767
- Peppol
- Registered · 0208:1004932767 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Jan 2024
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
TereLabs (SRL) has been based in Brussels since 2024, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 61,199 € and equity of 162,315 €; its revenue is not published. Its solvency stands at 78.1%, above the median of its sector (45.7%).
Companies similar to TereLabs
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- STXC Research and experimental development on natural sciences and engineering Aalst · balance sheet 210,455 €
- GMPharm Research and experimental development on natural sciences and engineering Perwez · balance sheet 215,626 €
- Ceperitus Research and experimental development on natural sciences and engineering Ghent · balance sheet 217,514 €
- Arquebus Solutions Europe Research and experimental development on natural sciences and engineering Machelen (Brab.) · balance sheet 186,058 €
- Hephaistos-Belgium Research and experimental development on natural sciences and engineering Liège · balance sheet 242,189 €
- ImmuneWatch Research and experimental development on natural sciences and engineering Antwerp · balance sheet 173,740 €
- OCTIMET Oncology Research and experimental development on natural sciences and engineering Geel · balance sheet 252,753 €
Frequently asked questions about TereLabs
What is the revenue of TereLabs?
TereLabs files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of TereLabs?
In Belgium, the VAT number is the company number prefixed with BE: BE1004932767 for TereLabs, if the company is VAT-registered. Its company number (CBE) is 1004.932.767.
Where is the registered office of TereLabs?
According to the CBE register, the registered office of TereLabs is in 1000 Brussels.
What is the equity of TereLabs?
At the close of the 2025 financial year, the equity of TereLabs amounts to 162,315 €, a solvency of 78.1% of total assets.
Who manages TereLabs?
The register lists 1 active mandates at TereLabs. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of TereLabs
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →